MARKET

DWTX

DWTX

Dogwood Therapeutics
NASDAQ
4.560
0.000
0.00%
After Hours: 4.560 0 0.00% 17:24 05/09 EDT
OPEN
4.470
PREV CLOSE
4.560
HIGH
4.780
LOW
4.470
VOLUME
104.56K
TURNOVER
--
52 WEEK HIGH
29.28
52 WEEK LOW
1.620
MARKET CAP
8.71M
P/E (TTM)
-0.3643
1D
5D
1M
3M
1Y
5Y
1D
Promising Growth Potential for Dogwood Therapeutics with Halneuron’s Development and Strong Financial Position
TipRanks · 6h ago
Dogwood Therapeutics, Inc. Reports Financial Results for the Quarter Ended March 31, 2025
Press release · 6h ago
Buy Rating for Dogwood Therapeutics Driven by Promising Clinical Developments and Strong Financial Outlook
TipRanks · 11h ago
Dogwood Therapeutics Reports Progress in Pain Treatment Trials
TipRanks · 17h ago
Virios Therapeutics Non-GAAP EPS of -$8.45
Seeking Alpha · 1d ago
Dogwood sees cash runway through 1Q26
TipRanks · 1d ago
Press Release: Dogwood Therapeutics Announces First Quarter 2025 Financial Results
Dow Jones · 1d ago
Press Release: Dogwood Therapeutics Announces -2-
Dow Jones · 1d ago
More
About DWTX
More
Dogwood Therapeutics, Inc. is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders. The Company’s research pipeline includes two separate mechanistic platforms with a non-opioid analgesic program and an antiviral program. The proprietary, non-opioid, Nav 1.7 analgesic program is centered on its lead development candidate, Halneuron, which is a specific voltage-gated sodium channel modulator, a mechanism known to be effective for reducing pain transmission. In clinical studies, Halneuron treatment has demonstrated pain reduction in pain related to general cancer and in pain related to chronic chemotherapy-induced neuropathic pain (CINP). The Company’s antiviral program includes IMC-1 and IMC-2, which are fixed-dose combinations of nucleoside analog, anti-herpes antivirals and the anti-inflammatory agent celecoxib for the treatment of fibromyalgia (FM) and Long-COVID (LC).
Recently
Symbol
Price
%Change

Webull offers Dogwood Therapeutics Inc stock information, including NASDAQ: DWTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DWTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DWTX stock methods without spending real money on the virtual paper trading platform.